Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>A=Bergh, Jonas$<.>)
Общее количество найденных документов : 44
Показаны документы с 1 по 20
 1-20    21-40   41-44 
1.
Accumulation of hyaluronic acid in the alveolar interstitial tissue in bleomycin-induced alveolitis // Amer. Rev. Respir. Disease, 1989. Vol. 139, N 3.-С.759-762

2.
Accumulation of hyaluronic acid in the alveolar interstitial tissue in bleomycin-induced alveolitis // Amer. Rev. Respir. Disease, 1989. Vol. 139, N 3.-С.759-762

3.
Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes // Carcinogenesis, 1994. Vol. 15, N 6.-С.1167-1173

4.
Assessment of sequence-based p53 gene analysis in human breast cancer: Messenger RNA in comparison with genomic DNA targets // Clin. Chem., 1998. Vol. 44, N 3.-С.455-462

5.
Bergh Mechanisms for acquired cytotoxic drug resistance in human small cell lung cancer and the potential utilization of resistance modifiers - a review with focus on in vitro studies // Lung. Cancer, 1990. Vol. 6, N 1-2.-С.9-15

6.
Bergh The Expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines Is related to tumor stroma formation in nude mice tumors // Amer. J. Pathol., 1988. Vol. 133, N 3.-С.434-439

7.
Biological response modifiers in the management of small cell lung cancer: a consensus report // Lung Cancer., 1989. Vol. 5, N 4-6.-С.143-145

8.
Biological response modifiers in the management of small cell lung cancer: a consensus report // Lung Cancer., 1989. Vol. 5, N 4-6.-С.143-145

9.
Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases // Anticancer Res., 1993. Vol. 13, N 5А.-С.1425-1430

10.
Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: Results from a randomized trial // J. Nat. Cancer Inst., 2005. Vol. 97, N 21.-С.1609-1610

11.
Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: Results from a randomized trial // J. Nat. Cancer Inst., 2005. Vol. 97, N 21.-С.1609-1610

12.
Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: Results from a randomized trial // J. Nat. Cancer Inst., 2005. Vol. 97, N 21.-С.1609-1610

13.
Cytotoxic action of cyclosporins on human tumor cell lines is not dependent on immunosupressive activity // Anticancer Res., 1992. Vol. 12, N 5.-С.1581-1586

14.
De Expression of the CD44 glycoprotein (Lymphocyte-Homing receptor) in untreated human breast cancer and its relationship to prognostic markers // Anticancer Res., 1995. Vol. 15, N 6b.-С.2791-2795

15.
De Expression of the CD44 glycoprotein (Lymphocyte-Homing receptor) in untreated human breast cancer and its relationship to prognostic markers // Anticancer Res., 1995. Vol. 15, N 6b.-С.2791-2795

16.
De Expression of the CD44 glycoprotein (Lymphocyte-Homing receptor) in untreated human breast cancer and its relationship to prognostic markers // Anticancer Res., 1995. Vol. 15, N 6b.-С.2791-2795

17.
Elucidation of the mechanism of homozygous deletion of 3p12'ЭКВИВ'13 in the U2020 cell line reveals the unexpected involvement of other chromosomes // Cancer Genet. and Cytogenet., 1999. Vol. 111, N 2.-С.105-110

18.
Enzymatic mutation detection method evaluated for detection of p53 mutations in cDNA from breast cancers // Clin. Chem., 2001. Vol. 47, N 5.-С.821-828

19.
Expression of an estramustine binding associated protein in human lung cancer cell lines // Cancer Res., 1988. Vol. 48, N 16.-С.4615-4619

20.
Fjallskog Is Cremophor EL, solvent for paclitaxel, cytotoxic? // Lancet, 1993, N 8875.-С.873

 1-20    21-40   41-44 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)